These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 19846025)
1. Telbivudine for the treatment of chronic hepatitis B infection. Hartwell D; Jones J; Harris P; Cooper K Health Technol Assess; 2009 Oct; 13 Suppl 3():23-30. PubMed ID: 19846025 [TBL] [Abstract][Full Text] [Related]
2. Entecavir for the treatment of chronic hepatitis B infection. Shepherd J; Gospodarevskaya E; Frampton G; Cooper K Health Technol Assess; 2009 Oct; 13 Suppl 3():31-6. PubMed ID: 19846026 [TBL] [Abstract][Full Text] [Related]
3. Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection. Jones J; Colquitt J; Shepherd J; Harris P; Cooper K Health Technol Assess; 2010 May; 14 Suppl 1():23-9. PubMed ID: 20507800 [TBL] [Abstract][Full Text] [Related]
4. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation. Shepherd J; Jones J; Takeda A; Davidson P; Price A Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047 [TBL] [Abstract][Full Text] [Related]
5. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients. Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234 [TBL] [Abstract][Full Text] [Related]
6. Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial. Hou J; Yin YK; Xu D; Tan D; Niu J; Zhou X; Wang Y; Zhu L; He Y; Ren H; Wan M; Chen C; Wu S; Chen Y; Xu J; Wang Q; Wei L; Chao G; Constance BF; Harb G; Brown NA; Jia J Hepatology; 2008 Feb; 47(2):447-54. PubMed ID: 18080339 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy. Lui YY; Tsoi KK; Wong VW; Kao JH; Hou JL; Teo EK; Mohamed R; Piratvisuth T; Han KH; Mihm U; Wong GL; Chan HL Antivir Ther; 2010; 15(2):145-55. PubMed ID: 20386069 [TBL] [Abstract][Full Text] [Related]
8. Telbivudine versus lamivudine in patients with chronic hepatitis B. Lai CL; Gane E; Liaw YF; Hsu CW; Thongsawat S; Wang Y; Chen Y; Heathcote EJ; Rasenack J; Bzowej N; Naoumov NV; Di Bisceglie AM; Zeuzem S; Moon YM; Goodman Z; Chao G; Constance BF; Brown NA; N Engl J Med; 2007 Dec; 357(25):2576-88. PubMed ID: 18094378 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of nucleoside analog therapy for hepatitis B in China: a Markov analysis. Wu B; Li T; Chen H; Shen J Value Health; 2010 Aug; 13(5):592-600. PubMed ID: 20561341 [TBL] [Abstract][Full Text] [Related]
10. 2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B. Liaw YF; Gane E; Leung N; Zeuzem S; Wang Y; Lai CL; Heathcote EJ; Manns M; Bzowej N; Niu J; Han SH; Hwang SG; Cakaloglu Y; Tong MJ; Papatheodoridis G; Chen Y; Brown NA; Albanis E; Galil K; Naoumov NV; Gastroenterology; 2009 Feb; 136(2):486-95. PubMed ID: 19027013 [TBL] [Abstract][Full Text] [Related]
11. Telbivudine for the management of chronic hepatitis B virus infection. Matthews SJ Clin Ther; 2007 Dec; 29(12):2635-53. PubMed ID: 18201580 [TBL] [Abstract][Full Text] [Related]
12. Trastuzumab for the treatment of primary breast cancer in HER2-positive women: a single technology appraisal. Ward S; Pilgrim H; Hind D Health Technol Assess; 2009 Jun; 13 Suppl 1():1-6. PubMed ID: 19567207 [TBL] [Abstract][Full Text] [Related]
13. Telbivudine in the treatment of chronic hepatitis B. Nash K Adv Ther; 2009 Feb; 26(2):155-69. PubMed ID: 19225726 [TBL] [Abstract][Full Text] [Related]
14. Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer. Greenhalgh J; McLeod C; Bagust A; Boland A; Fleeman N; Dundar Y; Oyee J; Dickson R; Davis H; Green J; McKenna E; Pearson M Health Technol Assess; 2010 Oct; 14(Suppl. 2):33-9. PubMed ID: 21047489 [TBL] [Abstract][Full Text] [Related]
15. Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B. Buti M; Brosa M; Casado MA; Rueda M; Esteban R J Hepatol; 2009 Oct; 51(4):640-6. PubMed ID: 19576651 [TBL] [Abstract][Full Text] [Related]
16. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal. Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028 [TBL] [Abstract][Full Text] [Related]
17. Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal. Stevenson M; Pandor A Health Technol Assess; 2009 Oct; 13 Suppl 3():37-42. PubMed ID: 19846027 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacoeconomic evaluation of telbivudine vs. lamivudine in treating the patients with HBeAg-positive and negative chronic hepatitis B]. Chen W; Hou JL Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):569-73. PubMed ID: 19719912 [TBL] [Abstract][Full Text] [Related]
19. Rituximab for the treatment of rheumatoid arthritis. Bagust A; Boland A; Hockenhull J; Fleeman N; Greenhalgh J; Dundar Y; Proudlove C; Kennedy T; Moots R; Williamson P; Dickson R Health Technol Assess; 2009 Sep; 13 Suppl 2():23-9. PubMed ID: 19804686 [TBL] [Abstract][Full Text] [Related]
20. Ustekinumab for the treatment of moderate to severe psoriasis. Gospodarevskaya E; Picot J; Cooper K; Loveman E; Takeda A Health Technol Assess; 2009 Oct; 13 Suppl 3():61-6. PubMed ID: 19846031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]